trial · primary record
EBV-TCR-T cells
EBV Emia and EBV Positive PTLD After Allogenic HSCT
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2021-10-31 |
| Primary endpoint | Percentage of adverse events |
| Registry ID | NCT04156217 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:12.105Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04156217
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.